Results
|
21.
|
Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia. [electronic resource] by
- McGraw, Kathy L
- Nguyen, Johnny
- Komrokji, Rami S
- Sallman, David
- Al Ali, Najla H
- Padron, Eric
- Lancet, Jeffrey E
- Moscinski, Lynn C
- List, Alan F
- Zhang, Ling
Producer: 20180202
In:
Haematologica vol. 101
Availability: No items available.
|
|
22.
|
Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia. [electronic resource] by
- Sweet, Kendra
- Al Ali, Najla H
- Dalia, Samir M
- Komrokji, Rami S
- Crescentini, Robert M
- Tinsley, Sara
- Lancet, Jeffrey E
- Papenhausen, Peter R
- Zhang, Ling
- Pinilla-Ibarz, Javier
Producer: 20150818
In:
International journal of hematology vol. 100
Availability: No items available.
|
|
23.
|
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes. [electronic resource] by
- Duong, Vu H
- Padron, Eric
- Al Ali, Najla H
- Lancet, Jeffrey E
- Hall, Jeff
- Kwok, Brian
- Zhang, Ling
- Epling-Burnette, Pearlie K
- List, Alan F
- Komrokji, Rami S
Producer: 20180111
In:
Annals of hematology vol. 97
Availability: No items available.
|
|
24.
|
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models. [electronic resource] by
- Duong, Vu H
- Lancet, Jeffrey E
- Alrawi, Ezzideen
- Al-Ali, Najla H
- Perkins, Janelle
- Field, Teresa
- Epling-Burnette, Pearlie K
- Zhang, Ling
- List, Alan F
- Komrokji, Rami S
Producer: 20130607
In:
Leukemia research vol. 37
Availability: No items available.
|
|
25.
|
Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution Experience. [electronic resource] by
- Chavez, Julio C
- Dalia, Samir
- Sandoval-Sus, Jose
- Kharfan-Dabaja, Mohamed A
- Al-Ali, Najla
- Komrokji, Rami
- Padron, Eric
- Corrales-Yepez, Gabriela
- Rock-Klotz, Jennifer
- Pinilla-Ibarz, Javier
Producer: 20160613
In:
Clinical lymphoma, myeloma & leukemia vol. 15 Suppl
Availability: No items available.
|
|
26.
|
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation. [electronic resource] by
- Kuykendall, Andrew T
- Shah, Savan
- Talati, Chetasi
- Al Ali, Najla
- Sweet, Kendra
- Padron, Eric
- Sallman, David A
- Lancet, Jeffrey E
- List, Alan F
- Zuckerman, Kenneth S
- Komrokji, Rami S
Producer: 20180215
In:
Annals of hematology vol. 97
Availability: No items available.
|
|
27.
|
Impact of tobacco usage on disease outcome in myelodysplastic syndromes. [electronic resource] by
- Mishra, Asmita
- Rollison, Dana E
- Brandon, Thomas H
- Al Ali, Najla H
- Corrales-Yepez, Maria
- Padron, Eric
- Epling-Burnette, Pearlie K
- Lancet, Jeffrey E
- List, Alan F
- Komrokji, Rami S
Producer: 20150813
In:
Leukemia research vol. 39
Availability: No items available.
|
|
28.
|
Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. [electronic resource] by
- Komrokji, Rami S
- Al Ali, Najla H
- Beg, M S
- Safa, Malek M
- Rollison, Dana
- Kharfan-Dabaja, Mohamed
- Bello, Celeste
- Cultrera, Jennifer
- Sokol, Lubomir
- Pinilla-Ibarz, Javier
- Sotomayor, Eduardo M
Producer: 20111003
In:
Clinical lymphoma, myeloma & leukemia vol. 11
Availability: No items available.
|
|
29.
|
Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes. [electronic resource] by
- McGraw, Kathy L
- Nguyen, Johnny
- Al Ali, Najla H
- Komrokji, Rami S
- Sallman, David
- Zhang, Xiaohui
- Song, Jinming
- Padron, Eric
- Lancet, Jeffrey E
- Moscinski, Lynn C
- List, Alan F
- Zhang, Ling
Producer: 20191029
In:
British journal of haematology vol. 184
Availability: No items available.
|
|
30.
|
Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment. [electronic resource] by
- Calleja, Anne
- Yun, Seongseok
- Moreilhon, Chimène
- Karsenti, Jean Michel
- Gastaud, Lauris
- Mannone, Lionel
- Komrokji, Rami
- Al Ali, Najla
- Dadone-Montaudie, Bérangère
- Robert, Guillaume
- Auberger, Patrick
- Raynaud, Sophie
- Sallman, David A
- Cluzeau, Thomas
Producer: 20210118
In:
European journal of haematology vol. 104
Availability: No items available.
|
|
31.
|
Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC). [electronic resource] by
- DeZern, Amy E
- Zeidan, Amer M
- Barnard, John
- Hand, Wesley
- Al Ali, Najla
- Brown, Francis
- Zimmerman, Cassie
- Roboz, Gail J
- Garcia-Manero, Guillermo
- Steensma, David P
- Komrokji, Rami S
- Sekeres, Mikkael A
Producer: 20180112
In:
Leukemia & lymphoma vol. 58
Availability: No items available.
|
|
32.
|
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes. [electronic resource] by
- Komrokji, Rami S
- Corrales-Yepez, Maria
- Kharfan-Dabaja, Mohamed A
- Al Ali, Najla H
- Padron, Eric
- Rollison, Dana E
- Pinilla-Ibarz, Javier
- Zhang, Ling
- Epling-Burnette, Pearlie K
- Lancet, Jeffrey E
- List, Alan F
Producer: 20130103
In:
American journal of hematology vol. 87
Availability: No items available.
|
|
33.
|
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better? [electronic resource] by
- Zeidan, Amer M
- Sekeres, Mikkael A
- Wang, Xiao-Feng
- Al Ali, Najla
- Garcia-Manero, Guillermo
- Steensma, David P
- Roboz, Gail
- Barnard, John
- Padron, Eric
- DeZern, Amy
- Maciejewski, Jaroslaw P
- List, Alan F
- Komrokji, Rami S
Producer: 20160122
In:
American journal of hematology vol. 90
Availability: No items available.
|
|
34.
|
Autoimmune diseases and myelodysplastic syndromes. [electronic resource] by
- Komrokji, Rami S
- Kulasekararaj, Austin
- Al Ali, Najla H
- Kordasti, Shahram
- Bart-Smith, Emily
- Craig, Benjamin M
- Padron, Eric
- Zhang, Ling
- Lancet, Jeffrey E
- Pinilla-Ibarz, Javier
- List, Alan F
- Mufti, Ghulam J
- Epling-Burnette, Pearlie K
Producer: 20160906
In:
American journal of hematology vol. 91
Availability: No items available.
|
|
35.
|
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy. [electronic resource] by
- Prebet, Thomas
- Cluzeau, Thomas
- Park, Sophie
- Sekeres, Mikkael A
- Germing, Ulrich
- Ades, Lionel
- Platzbecker, Uwe
- Gotze, Katharina
- Vey, Norbert
- Oliva, Esther
- Sugrue, Mary M
- Bally, Cecile
- Kelaidi, Charikleia
- Al Ali, Najla
- Fenaux, Pierre
- Gore, Steven D
- Komrokji, Rami
Publication details: Oncotarget Oct 2017
In:
Oncotarget vol. 8
Availability: No items available.
|
|
36.
|
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide. [electronic resource] by
- Rollison, Dana E
- Shain, Kenneth H
- Lee, Ji-Hyun
- Hampras, Shalaka S
- Fulp, William
- Fisher, Kate
- Al Ali, Najla H
- Padron, Eric
- Lancet, Jeffrey
- Xu, Qiang
- Olesnyckyj, Martha
- Kenvin, Laurie
- Knight, Robert
- Dalton, William
- List, Alan
- Komrokji, Rami S
Producer: 20171116
In:
Cancer medicine vol. 5
Availability: No items available.
|
|
37.
|
ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia. [electronic resource] by
- Padron, Eric
- Yoder, Sean
- Kunigal, Sateesh
- Mesa, Tania
- Teer, Jamie K
- Al Ali, Najla
- Sekeres, Mikkael A
- Painter, Jeffrey S
- Zhang, Ling
- Lancet, Jeffrey
- Maciejewski, Jaroslaw P
- Epling-Burnette, Pearlie K
- Sotomayor, Eduardo
- Komrokji, Rami S
- List, Alan F
Producer: 20140814
In:
Blood vol. 123
Availability: No items available.
|
|
38.
|
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities. [electronic resource] by
- Sallman, David A
- Barnard, John
- Al Ali, Najla H
- Garcia-Manero, Guillermo
- Sekeres, Mikkael A
- DeZern, Amy
- Steensma, David P
- Roboz, Gail
- Jabbour, Elias
- Maciejewski, Jaroslaw P
- Pierce, Sherry
- Padron, Eric
- Lancet, Jeffrey E
- Kantarjian, Hagop
- List, Alan F
- Komrokji, Rami S
Producer: 20210907
In:
Clinical lymphoma, myeloma & leukemia vol. 20
Availability: No items available.
|
|
39.
|
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents. [electronic resource] by
- Nazha, Aziz
- Sekeres, Mikkael A
- Garcia-Manero, Guillermo
- Barnard, John
- Al Ali, Najla H
- Roboz, Gail J
- Steensma, David P
- DeZern, Amy E
- Zimmerman, Cassie
- Jabbour, Elias J
- Zell, Katrina
- List, Alan F
- Kantarjian, Hagop M
- Maciejewski, Jaroslaw P
- Komrokji, Rami S
Producer: 20160613
In:
Leukemia research vol. 41
Availability: No items available.
|
|
40.
|
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. [electronic resource] by
- Kharfan-Dabaja, Mohamed A
- Komrokji, Rami S
- Zhang, Qing
- Kumar, Ambuj
- Tsalatsanis, Athanasios
- Perkins, Janelle
- Nishihori, Taiga
- Field, Teresa
- Al Ali, Najla
- Mishra, Asmita
- Sallman, David
- Salem, Karma Z
- Zhang, Ling
- Moscinski, Lynn
- Fernandez, Hugo F
- Lancet, Jeffrey
- List, Alan
- Anasetti, Claudio
- Padron, Eric
Producer: 20180703
In:
Clinical lymphoma, myeloma & leukemia vol. 17
Availability: No items available.
|